MKI67 and central nervous system cancer: In patients with high-grade glioma recurrence (subgroup 2), we observed a linear correlation between total tumor volume and exoDNA concentration, similar to what we observed in patients with low-grade glioma, although these two groups present clear differences in mitotic index and Ki-67 positivity.